Literature DB >> 2884531

Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy.

M A Edwards, A Green, A Colli, G Rylance.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2884531     DOI： 10.1016/s0140-6736(87)90631-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Successful treatment of severe cardiomyopathy with NTBC in a child with tyrosinaemia type I.

Authors:  N André; B Roquelaure; V Jubin; C Ovaert
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Liver repopulation for the treatment of metabolic diseases.

Authors:  M Grompe
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

3.  Cardiomyopathy in tyrosinaemia type I is common but usually benign.

Authors:  N Arora; O Stumper; J Wright; D A Kelly; P J McKiernan
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

4.  Visceral pathology of hereditary tyrosinemia type I.

Authors:  P Russo; S O'Regan
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 5.  Tyrosinaemia type I--an update.

Authors:  E A Kvittingen
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.